About Linearis
Linearis is a company based in Québec, Canada. It operates as a AI-as-a-Service and HealthTech. Linearis offers products and services including Metabolomics Testing and AI Drug Discovery.
- Headquarter Québec, Canada
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website linearis.com
- Social LinkedIn
Products & Services of Linearis
Linearis offers a comprehensive portfolio of products and services, including Metabolomics Testing and AI Drug Discovery.
Metabolomics testing is provided for disease signature identification.
AI-driven drug discovery is facilitated for metabolic diseases.
Similar companies to Linearis
10 companies that operate in the same segment as Linearis (Metabolic Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Developer of cortisol modulators for the treatment of various diseases | 1998 | Menlo Park, California, United States | – | USD 761.41 M | 500 | |
Developer of therapies for the treatment of endocrine-related diseases and cancers | 2008 | San Diego, California, United States | USD 103.5 M | USD 1.04 M | 437 | |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | 2009 | Cambridge, Massachusetts, United States | USD 685 M | – | 81 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Solutions for biomarker discovery and diagnostic testing are provided. | 2000 | Morrisville, United States | USD 165.87 M | – | – | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Linearis
Linearis is involved in pioneering metabolomics health testing and AI-driven solutions for metabolic diseases, including cancer and diabetes. The company operates through Linearis Labs and Linearis Ventures, focusing on the identification of multi-omics disease signatures. Its activities span prevention, treatment monitoring, and drug discovery. Investments are made in innovative life sciences companies to support advancements in healthcare. The platform being developed accelerates drug development, screening, and monitoring for various metabolomic conditions.
Linearis offers Metabolomics Testing and AI Drug Discovery.